AnaptysBio Inc.
ANAB | NASDAQ
$48.00
-$0.28 (-0.58%)
Nov 2, 2026, 9:47 AM ET · Market open
Market Data
Market Cap $1.44B
Enterprise Value $1.29B
Beta 0.41
Average Volume 577.99K
Shares Outstanding (Diluted) 35.98M
Shares Change YoY 24.87%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US0327241065
Price Performance
Price Change 1M -1.1%
Price Change 3M -10.6%
Price Change 6M -31.2%
Price Change YTD 48.5%
Price Change 1Y 99.8%
Price Change 3Y 310.6%
Price Change 5Y 111.6%
1M CAGR (ann.) -12.5%
1Y CAGR (ann.) 100.5%
5Y CAGR (ann.) 20.5%
All-Time CAGR 16.0%
Valuation
PE Ratio 8.99
Forward PE 11.55
PEG Ratio -0.00
Forward PEG -0.01
PS Ratio 6.07
Forward PS 5.90
PB Ratio 136.36
P/FCF Ratio 79.88
P/Adj. FCF Ratio -182.38
P/OCF Ratio 77.87
EV/Sales 5.44
EV/EBIT 9.10
EV/EBITDA 8.98
EV/FCF 71.52
Earnings Yield 11.1%
FCF Yield 1.3%
Adj. FCF Yield -0.6%
Financial Health
Net Debt $94.51M
Total Debt $13.1M
Cash & Short-Term Investments $164.14M
Total Assets $316.98M
Current Ratio 5.61
Quick Ratio 5.61
Debt / Equity Ratio 25.47
Debt / EBITDA 0.09
Debt / FCF 0.72
OCF / Debt 1.38
Interest Coverage 1.61
Altman Z-Score 2.84
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 133.1%
Operating Profit Margin 56.4%
EBITDA Margin 38.7%
Net Profit Margin 82.4%
FCF Margin 7.6%
Adj. FCF Margin -3.3%
SBC / Revenue 10.9%
SBC Impact (per share) -143.8%
Returns
Return on Assets 61.8%
Return on Equity 2515.2%
Return on Invested Capital 47.2%
Return on Capital Employed 47.5%
Return on Tangible Assets 61.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 163.9%
Revenue CAGR 5Y 18.6%
Revenue CAGR 10Y 28.5%
EPS CAGR 3Y 319.7%
EPS CAGR 5Y 66.2%
EPS CAGR 10Y 3.3%
FCF CAGR 3Y 92.5%
FCF CAGR 5Y 27.4%
FCF CAGR 10Y -8.4%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y 5.3%
Revenue Growth Next 3Y 11.2%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$1.84
EPS Growth Est (next Q) -453.9%
Revenue Est (next Q) $25.56M
Revenue Growth Est (next Q) -66.5%
Fair Value Estimates
Graham Number $6.60
Graham Upside -86.3%
Lynch Fair Value $134.25
Lynch Upside 178.1%
Price Target $79.17
Price Target Upside 64.0%
Cash Flow
Operating Cash Flow $18.08M
Free Cash Flow $18.07M
Adj. Free Cash Flow $-7.91M
FCF Per Share $0.62
OCF Per Share $0.62
OCF/S Ratio 7.6%
Income Statement
Revenue $237.61M
Gross Profit $261.15M
Operating Income $133.93M
EBITDA $143.83M
Net Income $195.72M
EPS (Diluted) $5.37
Revenue / Employee $2.28M
Profit / Employee $1.88M
Employees 104
Add to Watchlist
Select watchlists to add or remove ANAB